Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract
The purpose of this clinical research study is to learn if patients who receive vinflunine plus best supportive care live longer than patients who receive best supportive care alone. This study will also investigate patient benefit, safety and whether or not vinflunine shrinks or slows the growth of the cancer.
Transitional Cell Carcinoma of the Urothelial Tract|Bladder Cancer|Bladder Neoplasms
DRUG: vinflunine and best supportive care
duration of Overall Survival after Randomization, 30-March-07
patient benefit, 30-Mar-07|safety, 30-Mar-2007|response rate, throughout the study|time to response, upon occurrence|response duration, throughout the study|progression free survival, throughout the study
The purpose of this clinical research study is to learn if patients who receive vinflunine plus best supportive care live longer than patients who receive best supportive care alone. This study will also investigate patient benefit, safety and whether or not vinflunine shrinks or slows the growth of the cancer.